A phase II study
Philippe R Rougier, Antoine Adenis, Michel Pierre Ducreux et al. · European Journal of Cancer · 2000
Cited by 751 works. doi:10.1016/s0959-8049(00)00072-1
Authors
- Philippe R Rougier
- Antoine Adenis
- Michel Pierre Ducreux
- Marcel De Forni
- Jacques M Bonneterre
- M. Dembak
- P. Clouet
- Anne Lebecq
- P. Baille
- F Lefresne-Soulas
- Jean‐Pierre Armand
References
- Cancer: Principles and Practice of Oncology.
- Promotion of microtubule assembly in vitro by taxol
- Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
- Optimal two-stage designs for phase II clinical trials
- Pancreatic Cancer
- One-Sample Multiple Testing Procedure for Phase II Clinical Trials
- [Cancer of the pancreas].
- Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of Taxol
- Relationships between the structure of taxol analogs and their antimitotic activity
- Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas